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Stillbirth remains an event that has an important impact on global health issues. Different levels of health
care between countries suggest that the stillbirth rate may be one of the indicators of the quality of a
country’s medical system. In this review, major risk factors for stillbirth will be discussed, especially in
different trimesters of pregnancy. Early identiﬁcation of risk factors for stillbirth and appropriate ante-
natal management may reduce preventable stillbirths and improve general outcomes of pregnancy.
Copyright  2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
A stillbirth indicates a fetus born after 20 completed weeks of
pregnancy without spontaneous breath or heartbeat. It is equiva-
lent to intrauterine fetal demise in which no fetal heartbeat is
detected after 20 weeks of gestation. The estimated number of
stillbirths is 3.2 million a year worldwide. The incidence of stillbirth
varies from 5 to 32/1000 in different nations [1,2]. Developing
countries have higher stillbirth rates, up to 97%, than developed
countries [3,4]. Different levels of health care between countries
suggest the stillbirth ratemay be one of the indicators of the quality
of a country’s medical system. In Taiwan, the overall stillbirth rate
was 0.9e0.98% from 1999 to 2011 [5,6]. Our stillbirth ratewas lower
than 2.3% of East Asia but still higher than 0.3e0.5% of developed
countries when comparing to international stillbirth rates in 2000
[1,3]. Stillbirth has multifactorial etiologies. Early identiﬁcation of
risk factors for stillbirth and appropriate antenatal management
may reduce preventable stillbirths and improve the general out-
comes of pregnancy.Maternal characteristics
Advanced maternal age and increased maternal body mass in-
dex (BMI) are identiﬁed as risk factors of stillbirths [7,8]. The mean
maternal age at delivery has been increasing and gives a 1.6- to 2.6-s and Gynecology, National
l, 5F, 325, Section 2, Cheng-
bstetrics & Gynecology. Publishedfold risk increase for adverse perinatal outcomes [5,9]. In terms of
maternal BMI at delivery, the ethnic and cultural diversity, social
and economic conditions, and nutritional transitions are contrib-
utors to different average BMIs of the world’s population. The
increased stillbirth risk of the 3rd trimester compared to the 2nd
trimester may be attributable to a reasonable maternal body
weight increase as pregnancy progresses. Pregnant women and
their physicians should follow a well-controlled weight increase to
obtain better perinatal outcomes.
Smoking during pregnancy or exposure to environmental
smoke causes an increased risk of stillbirth [10e12]. Furthermore,
smoking carried into the 3rd trimester is found to have a more
signiﬁcant inﬂuence on the risk of stillbirth than smoking during
the 2nd trimester [6]. This may be attributable to the longer dura-
tion of cigarette exposure and the greater impact on the fetopla-
cental circulation. Smoking is a modiﬁable lifestyle choice, and its
effect should be preventable.
“Small for gestational age” is deﬁned as a birth weight below the
10th percentile for the gestational age. Nearly half of stillbirths are
small for their gestational age [7,13]. Besides the pathologic factors,
the time of recognition of intrauterine fetal demise may not be the
exact gestational age at which it happens. In Taiwan, regular
antenatal visits by government support staff are arranged every 1e
4 weeks, depending on the gestational age. The earlier the preg-
nancy stage, the longer the interval between antenatal visits.
Therefore, without notice of decreased fetal movement and early
diagnosis of stillbirth, there is reasonable intrauterine growth re-
striction data related to stillbirth. The reported fetal weight at de-
livery is smaller in Asia than in America [14,15]. To avoid the
misdiagnosis of intrauterine growth restriction, it is necessary toby Elsevier Taiwan LLC. All rights reserved.
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growth restrictions, adequate diagnosis and management offer a
signiﬁcant opportunity to improve outcomes and reduce poten-
tially preventable stillbirths [16]. Ultrasound accompanied by well-
managed control of illness should be used more frequently to
monitor fetal growth in the case of pregnancy complicated with a
high risk of placental dysfunction.Umbilical cord pathology
Umbilical cord pathology includes prolapse, true knots, stric-
ture, and strangulation of the fetus. The risk increases as the
pregnancy continues and may lead to more fetal demise outcomes
in late pregnancy, ranging from 19% to 56.6% of all stillbirths and a
rate of 5.7 per 1000 deliveries [2,17] (Table 1). Both a relatively
small intrauterine space and more frequent fetal movement are
found in late pregnancy. The risk of cord problems resulting in
vessel compression and cessation of blood ﬂow as well as fetal
perfusion in the 3rd trimester is higher [18,19]. Because most cord
accidents are sudden and unpredictable, pregnant women need to
pay attention to subjective fetal movement to prevent delayed
diagnosis. Fortunately, the prognosis for future pregnancies is
believed to be favorable.Unexplained causes
Despite extensive evaluations, stillbirths from uncertain reasons
account for 25e60% of total events, a rate of 2.8/1000 births [20,21].
In term pregnancy, the incidence of unexplained fetal demise could
be as high as 0.9/1000 births [22]. This number may be over-
estimated because of insufﬁcient diagnostic experience and
equipment in some nations. However, recognition of the potential
risk factors for stillbirth may indicate the possibility of problems
that can be addressed and solved with appropriate care. For those
with a high-risk pregnancy, paying more attention to the perinatal
period may be of beneﬁt to preventing intrauterine fetal demise.Maternal medical conditions
In general, the stillbirth rate would be 6e7/1000 when preg-
nancies are complicated with maternal diseases. There is about 10%
of all stillbirths being related to maternal medical illnesses [23].Table 1
Stillbirth causes.
% (in total stillbirths) Rate (per 1000 births)
Umbilical cord pathology 19e56.6 5.7

















Placental abruption 9e15.2 0.5
PROM¼ premature rupture of membranes; PPROM¼ preterm premature rupture of
membranes; SLE ¼ systemic lupus erythematosus.Among these diseases, hypertension and diabetes mellitus are the
most common.
Hypertensive pregnancy includes chronic hypertension, which
represents elevated blood pressure prior to the gestational age of
20weeks, and pregnancy-induced hypertension, whichmeans high
blood pressure that occurs after 20 weeks of pregnancy. Hyper-
tension is one of the most common medical conditions that
complicate pregnancy with an incidence of 7e10% [24,25]. The
disease would complicate proteinuria, often called preeclampsia.
About 5.6e9.4% of pregnancies complicated by preeclampsia end in
intrauterine fetal demise [26,27]. Hypertensive pregnancies are
responsible for 4e9% of all fetal deaths. The stillbirth rate is 5e52/
1000 births, depending on the severity of complications from hy-
pertension [23]. The pressure on the vascular system, including
maternalefetal circulation, indicates the same progressive vascular
effect on pregnancy. Complete antenatal diagnosis for preeclampsia
severity and education to prevent underestimation of high-risk
pregnancy and resulting tragedy are basic in perinatal manage-
ment. Prevention of the progression of preeclampsia and conse-
quent complications such as placenta abruption, which is also a
possible cause of intrauterine fetal demise, is still a major goal of
this high-risk pregnancy care.
As for diabetic pregnancy, when diabetes mellitus is diagnosed
before 20 weeks of pregnancy, it is called overt diabetes. There is a
2- to 5-fold risk of stillbirth for overt diabetes mellitus [28e30].
Risks of complication such as preeclampsia and stillbirth are also
increased in type 1 diabetic pregnancy as compared to pregnancy
in the general population, giving an odds ratio of 4.47 and 3.34,
respectively [31]. When diabetes mellitus is found after 20 weeks
of gestation, it is deﬁned as gestational diabetes mellitus. Diabetic
pregnancy is responsible for about 3% of all stillbirths. The still-
birth rate for pregnancies complicated by diabetes mellitus is 5e
35/1000 [20,23]. The complication would have a progressive ef-
fect on the overall maternal and fetal system in pregnancy. The
screen for gestational diabetes is done at 24e28 weeks of preg-
nancy. In some cases, unknown fetal demise that occurs prior to
24 weeks may be part of the cause of gestational diabetes melli-
tus. The risk of diabetic pregnancy and stillbirths may be under-
estimated. Under adequate treatment of gestational diabetes, the
pregnancy outcome is similar to that of the general population
[32].
Autoimmune and endocrine diseases, which occur more
frequently in women than in men, should be diagnosed for their
possible adverse pregnancy outcome. Hypothyroidism is a known
risk factor for pregnancy-induced hypertension, intrauterine
growth restriction, and intrauterine demise [33]. The prevalence of
overt and subclinical hypothyroidism is 0.1e2% and 2.3e8%,
respectively [34,35]. Hypothyroidism accounts for about 0.83% of
the total number of stillbirths [6]. The stillbirth rate is 0e125 of
1000 births [20]. It has an autoimmune process and has all the
aspects of the inﬂuence of pregnancy, including hypertension or
fetal anomalies. Delayed management of thyroid function creates a
higher risk of fetal complications such as fetal demise. Under
adequate treatment and well-managed control of hypothyroid
disease, the risk of fetal demise would be nomore increased than in
women without thyroid disease [36].
Systemic lupus erythematosus (SLE) is an autoimmune disease
with a cluster of phenomena. It mainly affects youngwomen during
their reproductive age, and pregnancy is therefore a major issue.
The overall stillbirth rate is 3.6e7.1% for pregnancy complicated by
SLE [37,38]. The stillbirth rates of 40e150 of 1000 births were
observed among women diagnosed with SLE prior to pregnancy
[20]. Antiphospholipid syndrome (APS), one kind of autoimmune-
related coagulation disorder, presents as recurrent spontaneous
pregnancy losses and repeated vascular thromboses. It can be a
Table 2
The leading causes of stillbirth in different trimesters and gestational ages.
2nd trimester 3rd trimester
<28 wk 28e36 wk 37 wk
Fretts [67] Infection (19%) Unexplained (26%) Unexplained (40%)
Placental abruption (14%) Fetal malnutritiona (19%) Fetal malnutrition (14%)
Anomalies (14%) Placental abruption (18%) Placental abruption (12%)
Stormdal Bring et al [68] IUGR/placental insufﬁciency (23.5%) Infection (26.3%)
Infection (18.7%) IUGR/placental insufﬁciency (20.5%)
Placental abruption (12.5%) Unexplained cause (14.5%)
Liu et al [6] Unexplained (29.8%) Umbilical cord pathology (33.3%)
Congenital anomaly and malformation (19.4%) Maternal medical condition (24.1%)
Umbilical cord pathology (16.4%)
Uterine complications (16.4%)
Unexplained (14.8%)
IUGR ¼ intrauterine growth restriction.
a Fetal malnutrition means an otherwise unexplained fetus weighing less than the 2.4%.
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such as SLE. Otherwise, some SLE patients carry antiphospholipid
antibodies that also meet the criteria and carry the risk for APS. APS
patients in pregnancies are not only related to frequent fetal loss
but also to a risk factor for intrauterine fetal demise [39]. Anti-
phospholipid antibodies were found among 9.5% of women with a
history of stillbirth [40]. The autoimmune disease would result in
thromboses and subsequent uteroplacental insufﬁciency [41]. Un-
treated pregnant patients with a high titer of antibodies have
approximately a 2830% probability of fetal loss, which often oc-
curs in the 2nd trimester [42].
Congenital anomaly and malformations and chromosomal
abnormalities
A fetus bornwith an abnormal anatomy can be infected or have
genetic abnormalities or a maternal disease such as diabetes
mellitus [43]. About 10e20% of stillbirths are attributed to
intrinsic fetal anomalies, giving a stillbirth rate of 0.5e0.9 per
1000 births [44,45]. One research determined that the risk of
major congenital anomaly among stillbirths was 20-fold higher
compared to that among live births, and most anomalies were
anencephaly [46]. Despite their normal karyotypes, those still-
births were highly suggestive of genetic abnormalities if there was
no other signiﬁcant maternal or environmental factor [46,47].
Chromosomal abnormalities of the fetus account for 6e13% of all
stillbirths. The type of chromosomal abnormalities found in still-
births is similar to the type found in live births. The leading type is
monosomy X and trisomy 21, followed by trisomy 18 and trisomy
13 [48]. Administering the antenatal serum Down screen test may
lead to many trisomy 21 fetuses being aborted early in pregnancy.
In the case of stillbirths with congenital anomaly and malforma-
tions or chromosomal abnormalities, better and complete coun-
seling should be provided to parents to prevent recurrent fetal
loss. Fortunately, most of the genetic etiologies of stillbirth are
from mutation, and most patients can still have normal preg-
nancies in the future [49].
Uterine complications
Preterm premature rupture of membranes (PPROM) is deﬁned
as rupture of the amnion and chorion prior to the gestational age
of 37 weeks, whereas premature rupture of membranes (PROM)
represents the same problem that occurs after the gestational age
of 37 weeks. The etiologies of PPROM or PROM are multifactorial,
and the prognosis depends on the gestational age. Any kind of
infection seems to play a major role, either being a cause or a
result of PPROM/PROM. The fetal outcome varies with the
gestational age. The stillbirth rates are 15e43% in PPROM in the2nd trimester [50,51], whereas the stillbirth rate is reduced to
4.5% in PPROM managed expectantly at the gestational age be-
tween 24 weeks and 28 weeks [52]. In general, PPROM/PROM
accounts for 0.8% of total stillbirths, a stillbirth rate of 0.03/1000
births [53] [Centre for Maternal and Child Enquiries (CMACE)
Perinatal Mortality 2009: United Kingdom; CMACE, London,
2011]. Chorioamnionitis, which is the inﬂammation of the uterus,
accounts for 22.6e36.9% of total stillbirths. The stillbirth rate
from chorioamnionitis is 0.83/1000 births [54,55]. After 28
weeks’ gestation, PPROM and chorioamnionitis would represent
nearly 6% of total stillbirths, whereas the percentage increased to
15% of stillbirths at less than 28 weeks’ gestation [10]. Cervical
incompetence is the painless dilation of the cervix in the 2nd
trimester, which easily leads to preterm birth. Cervical cerclage,
which gives a mechanical support to the cervix by the positioning
of a suture around the cervix, is one effective method to prevent
preterm birth. However, the procedure itself contains the risk of
failure or infection [56]. The risks of PPROM and chorioamnionitis
were 19.3% and 1.4% at elective cervical cerclage, respectively.
When the procedure was done in an emergency, the risks of
PPROM and chorioamnionitis were as signiﬁcantly high as 64.7%
and 42.9%, respectively [57]. When preterm threats present, the
maturity of the fetus and the chance to survive after birth are
important factors and make the difference in management
choices. All methods of prenatal treatment to delay delivery and
gain more maturity of the fetus still have the beneﬁt of pre-
venting stillbirth.
Uterine ﬁbroids are a common gynecologic disease with an
incidence rate of 30e70% among reproductive-age women [58].
Symptoms and complications of pregnancy are different according
to the location and size of the tumors. The risk of preterm birth and
intrauterine fetal demise are increased, especially with large ﬁ-
broids (>5 cm) [59,60]. Reduction of uterine distensibility from the
uterine ﬁbroids for the growing fetus may result in adverse peri-
natal outcomes, especially in late pregnancy.
Multifetal gestation complications
One research showed that multifetal gestation complicated by
growth restriction or growth discordance is associated with a
high risk of intrauterine fetal demise. Intrauterine fetal demise
following a multiple birth represented 7.3% of stillbirths. The
stillbirth rate for twin pregnancy was found to be 12e57/1000
[53,61]. Whether the fetal demise can be managed so as to limit
the fetal demise to one fetus in twin pregnancy depends on the
gestational age. Delaying the preterm labor of the surviving twin
is important to saving it successfully. In twin pregnancy, there is
usually a good prognosis for the surviving fetus when the other
fetus has suffered demise [62]. Multifetal gestation requires more
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complications.
Placental abruption
Placental abruption is deﬁned as the separation of the placenta
from the uterine wall prior to labor. Cessation of blood ﬂow and
subsequent acute asphyxia of the fetus are the most immediate
effects. The severity is positively associated with the causes and the
area of abruption. Placental abruption complicates 1e3.75% of
pregnancies [11,63] and accounts for 9e15.2% of total stillbirths.
The stillbirth rate from placental abruption is about 0.5/1000 birth
[11,64]. Although the majority of placental abruption cases are of
unknown cause, there are several predisposing factors to it,
including traumatic and nontraumatic factors. Traumatic factors
are accident related, whereas nontraumatic factors are usually
related to prior cesarean section, hypertensive disorders, parity,
maternal age, smoking, and gestational age [63,65,66]. Reduction of
the preventable stillbirths from placenta abruption can be achieved
by controlling the predisposing factors well.
Stillbirths in different trimesters and gestational ages
Fretts [67] reported that the most common causes for stillbirth
prior to and after 28 weeks of gestation are infection (19%) and
unexplained reason, respectively. Stormdal Bring et al [68] found
that the leading cause of preterm stillbirth was IUGR (intrauterine
growth restriction)/placental insufﬁciency (23.5%), whereas infec-
tion (26.3%) accounted for most term stillbirths. Placental abrup-
tion and preeclampsia/hypertension were more frequent in
preterm stillbirths than in term stillbirths. Umbilical cord compli-
cations and infection were more common in term/postterm still-
births compared with preterm stillbirths. Liu et al [6] revealed that
unexplained causes (29.8%) accounted for most stillbirths in the 2nd
trimester and umbilical cord pathology (33.3%) was themajor cause
of stillbirth in the 3rd trimester. The leading causes for stillbirth in
different trimesters and gestational ages are listed in Table 2. Re-
ports that include higher rates of causes of stillbirth in speciﬁc
trimesters of pregnancy would indicate a need for different ante-
natal care planning.
Conclusion
Stillbirth is always a tragedy. For those suffering from the sorrow
of a stillbirth, it is important to complete an evaluation to ﬁnd the
possible cause and to offer information about the risk of recurrence.
Women who have experienced prior fetal demise should be extra
aware in subsequent pregnancies of the possibility of preeclampsia,
placental abruption, and preterm delivery [69]. Along with
adequate antepartum examinations and education, medical
compliance from pregnant women will improve these pregnancy
outcomes.
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